Trump Administration to Consider Pharma Advertising Crackdown, Bloomberg reports

Published on 06/17/2025 at 10:04

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Sanofi

AstraZeneca RSV jab offers protection for premature babies in England	06:30am	AN
There's joy in the air	Jul. 18
Blueprint Medicines Corporation Announces Termination of Financing Agreement	Jul. 18	CI
Blueprint Medicines Corporation Announces Directorate and Committee Changes	Jul. 18	CI
Sanofi completed the acquisition of Blueprint Medicines Corporation from Sixth Street Partners, LLC.	Jul. 18	CI
Sanofi Closes Acquisition of Blueprint Medicines	Jul. 18	MT
Sanofi: acquires Blueprint	Jul. 18
Sanofi completes acquisition of Blueprint Medicines	Jul. 18	RE
Sanofi Closes Blueprint Medicines Purchase Following Tender Offer	Jul. 18	MT
Sanofi Closes Blueprint Medicines Purchase	Jul. 18	MT
SANOFI : JP Morgan reiterates its Neutral rating	Jul. 17	ZD
SANOFI : Gets a Neutral rating from Deutsche Bank	Jul. 17	ZD
Sanofi: Takeover bid for Blueprint extended by one day	Jul. 17
Sanofi Extends Tender Offer for US-based Blueprint Medicines	Jul. 17	MT
Sanofi announces extension of Blueprint tender offer	Jul. 17	RE
Thermo Fisher Scientific Inc. entered into an agreement to acquire Steriles Manufacturing Site in Ridgefield, New Jersey of Sanofi.	Jul. 16	CI
Thermo Fisher acquires Sanofi's New Jersey manufacturing site	Jul. 16	RE
Thermo Fisher Scientific Expands Partnership with Sanofi	Jul. 16	DJ
Thermo Fisher Scientific and Sanofi Expand Strategic Partnership to Enable Additional U.S. Drug Product Manufacturing	Jul. 16	CI
Price Data Softens Tariff Tensions Rise	Jul. 16
Thermo Fisher, Sanofi Expand Partnership With New Jersey Facility Deal	Jul. 16	MT
Thermo Fisher Scientific and Sanofi expand strategic partnership to enable additional U.S. drug product manufacturing	Jul. 16	RE
Sanofi Geographic Atrophy Treatment Gets FDA's Fast Track Designation	Jul. 16	DJ
Sanofi: fast track designation in GA due to AMD	Jul. 16
Sanofi's Sar446597 Earns Fast Track Designation in the US for Geographic Atrophy Due Toage-Related Macular Debutation	Jul. 16	CI